Aegon NV (NYSE:AEG) Stock Short Interest Report for October
by Tristan Rich · The Markets DailyAegon NV (NYSE:AEG – Get Free Report) was the recipient of a significant drop in short interest during the month of October. As of October 15th, there was short interest totaling 2,747,638 shares, a drop of 43.3% from the September 30th total of 4,845,750 shares. Based on an average trading volume of 7,261,224 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.1% of the company’s shares are short sold.
Aegon Price Performance
Shares of AEG stock traded down $0.12 on Friday, reaching $8.18. 4,391,786 shares of the company were exchanged, compared to its average volume of 7,194,010. The company has a 50-day moving average of $8.72 and a 200-day moving average of $8.30. Aegon has a one year low of $6.75 and a one year high of $9.61.
Aegon Cuts Dividend
The firm also recently announced a dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, September 3rd were paid a $0.2455 dividend. The ex-dividend date was Thursday, September 3rd. This is a negative change from Aegon’s previous dividend of $0.2469. This represents a dividend yield of 534.0%.
Analysts Set New Price Targets
Several analysts have issued reports on the stock. Citigroup reissued a “buy” rating on shares of Aegon in a research note on Tuesday, August 18th. Weiss Ratings upgraded shares of Aegon from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Tuesday. JPMorgan Chase & Co. downgraded Aegon from an “overweight” rating to a “neutral” rating in a research note on Thursday, October 22nd. Finally, Zacks Research upgraded Aegon from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 25th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $10.00.
Check Out Our Latest Report on AEG
Institutional Trading of Aegon
A number of institutional investors have recently made changes to their positions in the stock. Pathway Financial Advisers LLC purchased a new stake in Aegon in the third quarter worth about $31,000. Provenance Wealth Advisors LLC bought a new position in Aegon in the third quarter worth approximately $28,000. SYM FINANCIAL Corp purchased a new stake in shares of Aegon in the third quarter worth $98,000. Oppenheimer & Co. Inc. lifted its holdings in shares of Aegon by 2.4% in the third quarter. Oppenheimer & Co. Inc. now owns 619,982 shares of the financial services provider’s stock worth $5,350,000 after buying an additional 14,374 shares in the last quarter. Finally, Signaturefd LLC grew its holdings in shares of Aegon by 13.6% in the third quarter. Signaturefd LLC now owns 136,445 shares of the financial services provider’s stock valued at $1,178,000 after purchasing an additional 16,297 shares in the last quarter. Hedge funds and other institutional investors own 4.32% of the company’s stock.
Aegon Company Profile
Aegon N.V. is an international financial services company that provides insurance, retirement, and investment products. Its offerings include life insurance, annuities, pensions, retirement plans, employee benefits, and asset management services for individuals, employers, and institutional clients.
Aegon conducts much of its business through the Transamerica brand in the United States, offering retirement solutions, life insurance, investment products, and workplace benefits. The company also has operations in selected European markets, including the United Kingdom, Spain, and Portugal, as well as international asset management activities.
Headquartered in The Hague, the Netherlands, Aegon was formed in 1983 through the merger of Dutch insurers AGO and Ennia, whose roots extend back more than 175 years.
Featured Articles
- Five stocks we like better than Aegon
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?